Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the detailed record of transactions filed by Bizily Scott. Officer active across 1 company, notably 4D Molecular Therapeutics, Inc.. Cumulatively, 38 disclosures have been published. Split: 0 buy · 9 sells. Total volume traded: €185k. Activity tracked since 1 December 2022. The latest transaction was filed on 1 September 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Bizily Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
500 títulos@ 6,49 US$0.7% de su flujoCommon StockSEC:0000950170-24-045702:0
25 de 38 declaraciones
About Bizily Scott
Bizily Scott is Chief Legal Officer at 4D Molecular Therapeutics, Inc. The 32 filings recorded cover transactions from 2022-12-05 to 2026-07-02, and, within the recent filing sample held, the sell volume is EUR 143714 and the buy volume is EUR 0. The stated modal transaction nature is Levée d'options.